Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.10%) 5 332.75 points
Dow Jones Futures
(0.05%) 40 159 points
Nasdaq Futures
(0.18%) 18 668 points
Oil
(0.10%) $80.14
Gas
(1.49%) $2.67
Gold
(1.15%) $2 445.20
Silver
(2.42%) $32.02
Platinum
(-0.25%) $1 087.30
USD/EUR
(0.00%) $0.920
USD/NOK
(-0.01%) $10.67
USD/GBP
(0.10%) $0.788
USD/RUB
(-0.15%) $90.83

Realtime updates for Inventiva SA [IVA.PA]

Exchange: EURONEXT Industry: Biotechnology
Last Updated20 May 2024 @ 03:00
25% discount on Stockinvest.us - Use code: Podcast

0.00% € 3.60

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 03:00):

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases...

Stats
Today's Volume 1 698.00
Average Volume 59 965.00
Market Cap 188.54M
EPS €0 ( 2024-03-28 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -1.480
ATR14 €0.0150 (0.42%)

Volume Correlation

Long: -0.32 (neutral)
Short: -0.35 (neutral)
Signal:(59.417) Neutral

Inventiva SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Inventiva SA Correlation - Currency/Commodity

The country flag 0.05
( neutral )
The country flag -0.15
( neutral )
The country flag 0.00
( neutral )
The country flag -0.35
( neutral )
The country flag 0.19
( neutral )
The country flag -0.46
( neutral )

Inventiva SA Financials

Annual 2023
Revenue: €17.48M
Gross Profit: €17.50M (100.13 %)
EPS: €-2.43
FY 2023
Revenue: €17.48M
Gross Profit: €17.50M (100.13 %)
EPS: €-2.43
FY 2022
Revenue: €12.18M
Gross Profit: €11.18M (91.83 %)
EPS: €-1.310
FY 2021
Revenue: €4.19M
Gross Profit: €0.00 (0.00 %)
EPS: €-1.465

Financial Reports:

No articles found.

Inventiva SA Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Inventiva SA

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators